Overview

Naratriptan for the Treatment of Post Traumatic Headache Associated With Cognitive Dysfunction

Status:
Terminated
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether naratriptan, a medication approved for treatment of migraine, is effective in the treatment of post traumatic headache associated with cognitive dysfunction.
Phase:
Phase 4
Details
Lead Sponsor:
Cady, Roger, M.D.
Collaborators:
Clinvest
GlaxoSmithKline
Treatments:
Naratriptan